2MTW
Evidence supporting the hypothesis that specifically modifying a malaria peptide to fit into HLA-DR 1*03 molecules induces antibody production and protection
SOLUTION NMR
NMR Experiment | ||||||||
---|---|---|---|---|---|---|---|---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
1 | 2D DQF-COSY | 8 mM DMSO | DMSO | 3.7 | ambient | 295 | ||
2 | 2D 1H-1H TOCSY | 8 mM DMSO | DMSO | 3.7 | ambient | 295 | ||
3 | 2D 1H-1H NOESY | 8 mM DMSO | DMSO | 3.7 | ambient | 295 |
NMR Spectrometer Information | |||
---|---|---|---|
Spectrometer | Manufacturer | Model | Field Strength |
1 | Bruker | DRX | 600 |
NMR Refinement | ||
---|---|---|
Method | Details | Software |
distance geometry, DGSA-distance geometry simulated annealing | Insight II |
NMR Ensemble Information | |
---|---|
Conformer Selection Criteria | structures with the least restraint violations |
Conformers Calculated Total Number | 50 |
Conformers Submitted Total Number | 1 |
Representative Model | 1 (lowest energy) |
Computation: NMR Software | ||||
---|---|---|---|---|
# | Classification | Version | Software Name | Author |
1 | geometry optimization | Insight II | Accelrys Software Inc. | |
2 | refinement | Insight II | Accelrys Software Inc. |